Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1984 Dec;52(6):654–659. doi: 10.1136/hrt.52.6.654

Effect of prostaglandin on early surgical mortality in obstructive lesions of the systemic circulation.

F Leoni, J C Huhta, J Douglas, R MacKay, M R de Leval, F J Macartney, J Stark
PMCID: PMC481701  PMID: 6542422

Abstract

To examine the effect of preoperative prostaglandin infusion on surgical mortality the records of all patients aged less than or equal to 28 days operated between January 1979 and December 1981 for obstructive lesions of the systemic circulation were reviewed. Forty patients had coarctation of the aorta, five interrupted aortic arch, and seven critical aortic stenosis. Fourteen patients received intravenous prostaglandin before operation. Among preoperative variables low cardiac output was identified as a possible risk factor for hospital death, whereas the presence of a raised blood urea concentration was possibly significantly associated with hospital mortality only in patients not treated with prostaglandin. The preoperative administration of prostaglandin had a strongly favourable influence: 11 out of 38 (29.0%) patients who did not receive prostaglandin died compared with none of 14 treated with prostaglandin. The two groups were otherwise comparable with respect to the incidence of coagulopathy, urgency of operation, associated anomalies, and other medical treatment. Mean age at operation was younger and mean admission blood urea concentration higher in the group treated with prostaglandin, whereas the incidence of preoperative low cardiac output was probably higher. It is concluded that short term preoperative infusion of prostaglandin in associated with a significant reduction in early surgical mortality in this high risk group of infants.

Full text

PDF
654

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Browdie D. A., Norberg W., Agnew R., Altenburg B., Ignacio R., Hamilton C. The use of prostaglandin E1 and Blalock-Taussig shunts in neonates with cyanotic congenital heart disease. Ann Thorac Surg. 1979 Jun;27(6):508–513. doi: 10.1016/s0003-4975(10)63359-0. [DOI] [PubMed] [Google Scholar]
  2. Clyman R. I., Heymann M. A., Rudolph A. M. Ductus arteriosus responses to prostaglandin E1 at high and low oxygen concentrations. Prostaglandins. 1977 Feb;13(2):219–223. doi: 10.1016/0090-6980(77)90003-x. [DOI] [PubMed] [Google Scholar]
  3. Coceani F., Olley P. M. The response of the ductus arteriosus to prostaglandins. Can J Physiol Pharmacol. 1973 Mar;51(3):220–225. doi: 10.1139/y73-031. [DOI] [PubMed] [Google Scholar]
  4. Elliott R. B., Starling M. B., Neutze J. M. Medical manipulation of the ductus arteriosus. Lancet. 1975 Jan 18;1(7899):140–142. doi: 10.1016/s0140-6736(75)91432-4. [DOI] [PubMed] [Google Scholar]
  5. Freed M. D., Heymann M. A., Lewis A. B., Roehl S. L., Kensey R. C. Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease. Circulation. 1981 Nov;64(5):899–905. doi: 10.1161/01.cir.64.5.899. [DOI] [PubMed] [Google Scholar]
  6. Graham T. P., Atwood G. F., Boucek R. J. Use of prostaglandin E1 for emergency palliation of symptomatic coarctation of the Aorta. Cathet Cardiovasc Diagn. 1978;4(1):97–102. doi: 10.1002/ccd.1810040114. [DOI] [PubMed] [Google Scholar]
  7. Graham T. P., Jr, Atwood G. F., Boerth R. C., Boucek R. J., Jr, Smith C. W. Right and left heart size and function in infants with symptomatic coarctation. Circulation. 1977 Oct;56(4 Pt 1):641–647. doi: 10.1161/01.cir.56.4.641. [DOI] [PubMed] [Google Scholar]
  8. Heymann M. A., Berman W., Jr, Rudolph A. M., Whitman V. Dilatation of the ductus arteriosus by prostaglandin E1 in aortic arch abnormalities. Circulation. 1979 Jan;59(1):169–173. doi: 10.1161/01.cir.59.1.169. [DOI] [PubMed] [Google Scholar]
  9. Ho S. Y., Anderson R. H. Coarctation, tubular hypoplasia, and the ductus arteriosus. Histological study of 35 specimens. Br Heart J. 1979 Mar;41(3):268–274. doi: 10.1136/hrt.41.3.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lang P., Freed M. D., Rosenthal A., Castaneda A. R., Nadas A. S. The use of prostaglandin E1 in an infant with interruption of the aortic arch. J Pediatr. 1977 Nov;91(5):805–807. doi: 10.1016/s0022-3476(77)81047-0. [DOI] [PubMed] [Google Scholar]
  11. Leanage R., Taylor J. F., de Leval M. R., Stark J., Macartney F. J. Surgical management of coarctation of aorta with ventricular septal defect. Multivariate analysis. Br Heart J. 1981 Sep;46(3):269–277. doi: 10.1136/hrt.46.3.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Neutze J. M., Starling M. B., Elliott R. B., Barratt-Boyes B. G. Palliation of cyanotic congenital heart disease in infancy with E-type prostaglandins. Circulation. 1977 Feb;55(2):238–241. doi: 10.1161/01.cir.55.2.238. [DOI] [PubMed] [Google Scholar]
  13. Olley P. M., Coceani F., Bodach E. E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations. Circulation. 1976 Apr;53(4):728–731. doi: 10.1161/01.cir.53.4.728. [DOI] [PubMed] [Google Scholar]
  14. Radford D. J., Bloom K. R., Coceani F., Fariello R., Olley P. M. Letter: Prostaglandin E1 for interrupted aortic arch in the neonate. Lancet. 1976 Jul 10;2(7976):95–95. doi: 10.1016/s0140-6736(76)92309-6. [DOI] [PubMed] [Google Scholar]
  15. Report of the New England Regional Infant Cardiac Program. Pediatrics. 1980 Feb;65(2 Pt 2):375–461. [PubMed] [Google Scholar]
  16. Rigden S. P., Barratt T. M., Dillon M. J., De Leval M., Stark J. Acute renal failure complicating cardiopulmonary bypass surgery. Arch Dis Child. 1982 Jun;57(6):425–430. doi: 10.1136/adc.57.6.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rudolph A. M., Heymann M. A., Spitznas U. Hemodynamic considerations in the development of narrowing of the aorta. Am J Cardiol. 1972 Oct;30(5):514–525. doi: 10.1016/0002-9149(72)90042-2. [DOI] [PubMed] [Google Scholar]
  18. Sharpe G. L., Larsson K. S. Studies on closure of the ductus arteriosus. X. In vivo effect of prostaglandin. Prostaglandins. 1975 May;9(5):703–719. doi: 10.1016/0090-6980(75)90109-4. [DOI] [PubMed] [Google Scholar]
  19. Silove E. D., Coe J. Y., Shiu M. F., Brunt J. D., Page A. J., Singh S. P., Mitchell M. D. Oral prostaglandin E2 in ductus-dependent pulmonary circulation. Circulation. 1981 Mar;63(3):682–688. doi: 10.1161/01.cir.63.3.682. [DOI] [PubMed] [Google Scholar]
  20. Zahka K. G., Roland J. M., Cutilletta A. F., Gardner T. J., Donahoo J. S., Kidd L. Management of aortic arch interruption with prostaglandin E1 infusion and microporous expanded polytetrafluoroethylene grafts. Am J Cardiol. 1980 Dec 1;46(6):1001–1005. doi: 10.1016/0002-9149(80)90358-6. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES